Carla Pieresca
-
- Lymphoma Diagnosis and Treatment 15
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 9
- Hematology top 10%
- Multiple Myeloma Research and Treatments 3
- Gastroenterology top 10%
-
- Viral-associated cancers and disorders 4
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 6
-
- CNS Lymphoma Diagnosis and Treatment 2
-
- T-cell and Retrovirus Studies 1
In The Last Decade
Carla Pieresca
23 papers receiving 475 citations
Peers
Comparison fields: 5 of 43
- Pathology and Forensic Medicine 362
- Genetics 148
- Hematology 102
- Gastroenterology 40
- Oncology 188
Countries citing papers authored by Carla Pieresca
This map shows the geographic impact of Carla Pieresca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Pieresca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Pieresca more than expected).
Fields of papers citing papers by Carla Pieresca
This network shows the impact of papers produced by Carla Pieresca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Pieresca. The network helps show where Carla Pieresca may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carla Pieresca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 16 | |
| 2 | 2007 | 8 | |
| 3 | Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL). | 1998 | 4 |
| 4 | 1998 | 27 | |
| 5 | CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL). | 1997 | 5 |
| 6 | 1997 | 10 | |
| 7 | 1996 | 25 | |
| 8 | 1996 | 55 | |
| 9 | 1995 | 19 | |
| 10 | 1995 | 9 | |
| 11 | Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD). | 1994 | 25 |
| 12 | 1994 | 79 | |
| 13 | 1993 | 25 | |
| 14 | MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease. | 1993 | 7 |
| 15 | 1992 | 6 | |
| 16 | 1991 | 5 | |
| 17 | 1990 | 8 | |
| 18 | 1990 | 95 | |
| 19 | 1989 | 9 | |
| 20 | The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients. | 1988 | 8 |
About Carla Pieresca
Carla Pieresca is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 23 papers that have together received 489 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lung Cancer Treatments and Mutations (6 papers), Viral-associated cancers and disorders (4 papers), Multiple Myeloma Research and Treatments (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (362 citations), Genetics (148 citations), Hematology (102 citations), Gastroenterology (40 citations) and Oncology (188 citations). Carla Pieresca has collaborated with scholars based in Italy, Germany and Greece. Frequent co-authors include Giovanni Grignani, Daniele Bertoloni, Paolo G. Gobbi, P. Gobbi, Edoardo Ascari, E Ascari, Luigi Cavanna, Paolo Dionigi, V. Jemos and Massimo Federico. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Blood, Acta Haematologica and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.